TABLE 1.
Patient | Age | Sex | BMI | CCI | PS | %FEV1 | %DLCO | cTNM | ypTNM | RR a | EGFR mutation |
---|---|---|---|---|---|---|---|---|---|---|---|
Case 1 | 71 | Male | 13.67 | 0 | 1 | 89 | 59 | IIIb,cT3N2M0 | IIIa,ypT1bN2M0 | PD | L858R |
Case 2 | 62 | Female | 21.72 | 0 | 1 | 89 | 116 | IIb,cT3N0M0 | Ia3,ypT1cN0M0 | PR | L858R |
Case 3 | 64 | Female | 23.61 | 0 | 1 | 94 | 92 | IIIa,cT2bN2M0 | Ia3,ypT1cN0M0 | PR | L861Q |
Case 4 | 55 | Male | 23.23 | 0 | 0 | 123 | 96 | IIb,cT1cN1M0 | Ia2,ypT1bN0M0 | SD | L858R |
Case 5 | 68 | Female | 23.49 | 0 | 0 | 113 | 103 | IIb,cT2aN1M0 | Ib,ypT2aN0M0 | PR | L861Q |
Case 6 | 56 | Male | 23.94 | 0 | 0 | 129 | NA | IIIa,cT1bN2M0 | Ia1,ypT1aN0M0 | SD | 19del |
Case 7 | 46 | Male | 26.03 | 0 | 1 | 116 | NA | IIb,cT3N0M0 | Ia3,ypT1cN0M0 | PR | 19del |
Case 8 | 52 | Female | 21.64 | 0 | 1 | 109 | NA | IIb,cT2bN1M0 | Ia2,ypT1bN0M0 | PR | 19del |
Case 9 | 45 | Female | 21.48 | 0 | 1 | 99 | NA | IIIa,cT4N0M0 | IIa,ypT2bN0M0 | PR | L858R |
Case 10 | 67 | Female | 17.09 | 0 | 1 | 107 | 129 | Ib,cT2aN0M0 | Ia3,ypT1cN0M0 | PR | L858R |
Case 11 | 57 | Female | 24.62 | 2 | 1 | 76 | 89 | IIIa,cT3N1M0 | IIb,ypT1cN1M0 | PR | L858R |
Case 12 | 58 | Male | 21.08 | 1 | 0 | 100 | NA | IIIa,cT2aN2M0 | Ia3,ypT1cN0M0 | SD | 19del |
Case 13 | 52 | Female | 24.84 | 0 | 1 | 95 | 81 | IIIb,cT3N2M0 | IIIa,ypT1bN2M0 | PR | 19del |
RR, radiologic response.